Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danica M Vodopivec

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Medical Oncology|June 27, 2022
RET kinase inhibitors for <i>RET</i>-altered thyroid cancersDanica M Vodopivec, Mimi I Hu
Current Treatment Options in Oncology|November 18, 2023
The Evolving Treatment Landscape of Medullary Thyroid CancerMarta Laganà, Valentina Cremaschi, Andrea Alberti, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 5, 2021
Authors' Reply: Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?Nipith Charoenngam, Arash Shirvani, Niyoti Reddy, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 11, 2021
Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19Nipith Charoenngam, Arash Shirvani, Niyoti Reddy, et al.
The New England Journal of Medicine|December 2, 2020
Looking for the OutsiderDanica M Vodopivec, Dylan D Thomas, Nadine E Palermo, et al.
JCO Precision Oncology|February 20, 2026
Acquired Driver Fusions as a Mechanism of Resistance to Selective RET Inhibitors in Advanced Medullary Thyroid CarcinomaSarah Hamidi, Vivek Subbiah, Maria E Cabanillas, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidismDanica M Vodopivec, Angelica M Silva, Dinamarie C Garcia-Banigan, et al.
Clinical Endocrinology|March 9, 2017
Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1?Wei Qiu, Ioannis Christakis, Ashley A Stewart, et al.
World Journal of Surgery|October 4, 2022
Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone LevelsMichael S Lui, Uriel Clemente-Gutierrez, Danica M Vodopivec, et al.
Surgery|November 22, 2023
Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Thomas Szabo Yamashita, Aditya S Shirali, Salyna Meas, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Medical Oncology|June 27, 2022
RET kinase inhibitors for <i>RET</i>-altered thyroid cancersDanica M Vodopivec, Mimi I Hu
Current Treatment Options in Oncology|November 18, 2023
The Evolving Treatment Landscape of Medullary Thyroid CancerMarta Laganà, Valentina Cremaschi, Andrea Alberti, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 5, 2021
Authors' Reply: Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?Nipith Charoenngam, Arash Shirvani, Niyoti Reddy, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 11, 2021
Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19Nipith Charoenngam, Arash Shirvani, Niyoti Reddy, et al.
The New England Journal of Medicine|December 2, 2020
Looking for the OutsiderDanica M Vodopivec, Dylan D Thomas, Nadine E Palermo, et al.
JCO Precision Oncology|February 20, 2026
Acquired Driver Fusions as a Mechanism of Resistance to Selective RET Inhibitors in Advanced Medullary Thyroid CarcinomaSarah Hamidi, Vivek Subbiah, Maria E Cabanillas, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidismDanica M Vodopivec, Angelica M Silva, Dinamarie C Garcia-Banigan, et al.
Clinical Endocrinology|March 9, 2017
Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1?Wei Qiu, Ioannis Christakis, Ashley A Stewart, et al.
World Journal of Surgery|October 4, 2022
Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone LevelsMichael S Lui, Uriel Clemente-Gutierrez, Danica M Vodopivec, et al.
Surgery|November 22, 2023
Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Thomas Szabo Yamashita, Aditya S Shirali, Salyna Meas, et al.
Pageof 2